Medicare Enrolled

Dr. Julia Hargesheimer, NP

Nurse Practitioner - Adult Health · Lubbock, TX
Low-engagement
7008 SALEM AVE # 117, Lubbock, TX 79424
8009247811
In practice since 2009 (17 years)
NPI: 1427298801 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hargesheimer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hargesheimer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hargesheimer

Dr. Julia Hargesheimer is a nurse practitioner - adult health in Lubbock, TX, with 17 years in practice.

Between the years covered by Open Payments, Dr. Hargesheimer received a total of $5,518 from 31 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hargesheimer is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $5,518 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,518
Total received (2021-2024)
Avg $1,379/year across 4 years
Top 6% in TX for nurse practitioner - adult health
31
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,518 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$579
2023
$1,751
2022
$1,747
2021
$1,440

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,218
Amgen Inc.
$796
Lilly USA, LLC
$510
ABBVIE INC.
$425
PFIZER INC.
$338
Janssen Biotech, Inc.
$268
UCB, Inc.
$235
Radius Health, Inc.
$166
Horizon Therapeutics plc
$163
Genentech USA, Inc.
$159
E.R. Squibb & Sons, L.L.C.
$153
Pacira Therapeutics, Inc.
$145
Aurinia Pharma U.S., Inc.
$139
Actelion Pharmaceuticals US, Inc.
$104
Mallinckrodt Hospital Products Inc.
$98
Ferring Pharmaceuticals Inc.
$88
AstraZeneca Pharmaceuticals LP
$79
Neurelis, Inc.
$65
Octapharma USA, Inc.
$60
GlaxoSmithKline, LLC.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$42
Neurocrine Biosciences, Inc.
$32
Corium, LLC
$31
Sandoz Inc.
$28
Bioventus LLC
$21
Alexion Pharmaceuticals, Inc.
$20
Fresenius Kabi USA, LLC
$20
Teva Pharmaceuticals USA, Inc.
$16
Lundbeck LLC
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 45.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Adlarity · Aimovig · Austedo XR · BENLYSTA · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · Enspryng · GAMMAGARD · HYRIMOZ · IDACIO · INGREZZA · KRYSTEXXA · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPSUMIT · ORENCIA · PANZYGA · QULIPTA · REDITREX · REMICADE · REXULTI · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · Supartz FX Sodium Hyaluronate · TALTZ · TAVNEOS · TREMFYA · Tymlos · UBRELVY · UPTRAVI · Ultomiris · VALTOCO · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for nurse practitioner - adult health in TX.

Looking for a nurse practitioner - adult health in Lubbock?
Compare nurse practitioner - adult healths in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - adult healths nearby

Geographic Context

Nurse Practitioner - Adult Healths within 10 mi
6
Per 100K population
1.9
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hargesheimer is a nurse practitioner - adult health, and high industry engagement (low-engagement, top 6%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Hargesheimer receive payments from pharmaceutical companies?
Yes. Dr. Hargesheimer received a total of $5,518 from 31 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Hargesheimer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Nurse Practitioner - Adult Healths in Lubbock
Browse nurse practitioner - adult healths in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Nurse Practitioner - Adult Healths in TX
Nurse Practitioner - Adult Healths ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nurse Practitioner - Adult Healths in TX
Which TX nurse practitioner - adult healths receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →